EP2145891A1 — 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
Assigned to Vetoquinol SA · Expires 2010-01-20 · 16y expired
What this patent protects
A subject of the invention is the compounds of formula (I): wherein R 1 , R 2 , R 3 , R' 3 , R 4 , R' 4 , R 5 , R 6 and R 7 are as described in the application, in the form of enantiomers or mixtures, as well as their salts with acids and bases, their preparation and the…
USPTO Abstract
A subject of the invention is the compounds of formula (I): wherein R 1 , R 2 , R 3 , R' 3 , R 4 , R' 4 , R 5 , R 6 and R 7 are as described in the application, in the form of enantiomers or mixtures, as well as their salts with acids and bases, their preparation and their application as anti-bacterials, in both human and veterinary medicine.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.